Related Experiment Videos
Late transcatheter removal of a Rashkind PDA occlusion device for persistent hemolysis using a modified transseptal
R G Grifka1, M P O'Laughlin, C E Mullins
1Baylor College of Medicine, Houston, TX.
Catheterization and Cardiovascular Diagnosis
|February 1, 1992
Abstract:
A patient developed hemolysis and hematuria 2 d after placement of a 12 mm Rashkind PDA occlusion device. Six days after placement, the device was snared from the ductus arteriosus and removed through a modified transseptal sheath. A 17 mm PDA occlusion device was successfully placed in the PDA, with resolution of the hematuria.